In vitro and in vivo activity of 12-O-3-N-dansylamino TPA.
Dansyl-TPA, a fluorescent TPA analogue, which is a label with a high affinity for C3H/10T1/2 cells and induces 3H-choline release from these cells (Tran et al. Nouv. J. Chim 1984, 8, 751-757), has been studied for in vitro promoting activity in the same cell line initiated by a carcinogen MNNG and in vivo short-term mouse skin tests. In vitro, dansyl-TPA expresses transforming effect in its own (without MNNG pretreatment) as well as increases the production of transformed foci in MNNG-treated cells. In in vivo skin tests, dansyl-TPA displays lower effects than TPA on mouse skin. These results indicate a low promoting potential of dansyl-TPA.
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced; D002478:Cells, Cultured; D003619:Dansyl Compounds / Q000009:adverse effects / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D051379:Mice; D013755:Tetradecanoylphorbol Acetate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D013997:Time Factors
D003619:Dansyl Compounds; C043670:O-(N-dansylamino-3-tetradecanoyl)-12,O-acetyl-13-phorbol; D013755:Tetradecanoylphorbol Acetate